U.S. FDA Approves Pipeline™ Flex Embolization Device with Shield Technology™

Medtronic plc has received U.S. FDA approval for Pipeline™ Flex Embolization Device with Shield Technology™. Background An estimated 500,000 people throughout the … continue reading “U.S. FDA Approves Pipeline™ Flex Embolization Device with Shield Technology™”

Medtronic’s ENT Portfolio Grows with FDA Clearance of NIM Vital and Acquisition of Ai Biomed

Medtronic plc, has received U.S. FDA 510(k) clearance of the NIM Vital™ nerve monitoring system, which enables physicians to identify, … continue reading “Medtronic’s ENT Portfolio Grows with FDA Clearance of NIM Vital and Acquisition of Ai Biomed”

Medtronic DTM™ Spinal Cord Stimulation Therapy Outperforms Conventional SCS Therapy for Back Pain Relief at 12 Months

Statistically significant 12-month results from a large, multicenter randomized controlled trial confirm 84% Back Pain Responder Rate and 69% Profound … continue reading “Medtronic DTM™ Spinal Cord Stimulation Therapy Outperforms Conventional SCS Therapy for Back Pain Relief at 12 Months”